The FDA warns HeartSine Technologies for violations related to adverse event reporting standards and medical device tracking at a Pennsylvania AED manufacturing facility.
HeartSine Technologies is in more hot water with the FDA this month after receiving an agency warning letter citing medical device reporting and tracking violations at a Pennsylvania facility.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1eUUPJF
Cap comentari:
Publica un comentari a l'entrada